检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]东莞市中医院,广东东莞523005
出 处:《新中医》2011年第2期66-68,共3页New Chinese Medicine
摘 要:目的:观察软坚散结法对动脉粥样硬化斑块的防治作用。方法:将132例动脉粥样硬化的病人,随机分成对照组65例和治疗组67例,治疗组采用心脉康方每天1剂口服;对照组采用血脂康胶囊治疗。2组均给药3月。结果:2组总有效率比较,差异无显著性意义(P>0.05)。治疗组治疗后血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和对照组治疗后TG、TC、LDL-C分别与治疗前比较,差异均有显著性意义(P<0.05)。2组治疗后TG、LDL-C、HDL-C比较,差异均有显著性意义(P<0.05)。2组治疗前后动脉内膜-中膜厚度(IMT)、斑块消退比较,差异有显著性或非常显著性意义(P<0.05,P<0.01)。2组治疗后斑块消退比较,差异有显著性意义(P<0.05)。2组治疗期间心脑血管事件发生和再住院情况比较,差异均有非常显著性意义(P<0.01)。结论:软坚散结法能降低血脂,改善动脉粥样硬化。Objective: To evaluate the preventive and therapeutic effect of therapy of softening hardness and dissipating mass for atherosclerosis. Methods: One hundred and thirty-two atherosclerosis patients were randomly divided into two groups. The control group (n=65) received Xuezhikang Tablet, and the treatment group (n=67) received the decoction of Xinmaikang Prescription, one dose per day. The treatment lasted 3 months. Results: No statistical significant difference of the total effective rate was found between two groups (P 〉 0.05). After treatment, serum levels of total cholesterol(TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C)in the treatment group differed from those before treatment(P 〈 0.05). So did TG, TC, LDL-C in the control group(P 〈 0.05). The differences of TG, LDL-C, HDL-C were significant between two groups after treatment (P 〈 0.05). Significant or obviously significant differences of the intima-media thickness and plaques subsidence were found in both groups before and after treatment (P 〈 0.05). The difference of plaques subsidence was significant between two groups after treatment (P 〈 0.05). During the treatment, the differences of the incidences of cardiovascular event and rehospitalization were significant between two groups (P 〈 0.05). Conclusion: Xinmaikang can decrease blood lipid levels, and can alleviate atherosclerosis.
分 类 号:R543.5[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28